(S)-3-((tert-Butoxycarbonyl)amino)-4-(1H-indol-3-yl)butanoic acid, 95.0%, 250mg

(2S,2'S,3S,3'S)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 50mg

7-Chloroisoquinolin-1-ol, 95.0%, 5g

Thiophene-3,4-dicarboxylic acid, 98.0%, 5g

Boc-Gly-Pro, 95.0%, 25g

2-Amino-5-bromonicotinaldehyde, 95.0%, 5g

2,4-Diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidine, 98%, 5g

Brilliant blue FCF (CI 42090), 25 g, glass packaging

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 0.50 µm, 1 Piece(s)

N-(4-Fluorophenyl)formamide>98.0%(GC)5g

DIIODINE-PEG3, 95.0%, 10g

9-[2-(Diphenylphosphino)phenyl]-9H-carbazole, 97%, 250mg

(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione, 95.0%, 500mg